58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER Palazzo della GRAN GUARDIA. Preliminary Program

Similar documents
58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER Palazzo della GRAN GUARDIA. First Announcement

Dangerous Liaisons. Ferrara, September Università degli Studi di Ferrara. translating cancer biology into better patients management

53 rd Annual Meeting of the

Resolving Cancer Heterogeneity:

Scientific Programme

Promises and challenges of developing new drugs in oncology

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

SIC SCIENTIFIC BOARD SCIENTIFIC AND ORGANIZING COMMITTEE

55 th. Catanzaro September Xxxxxxxxxxxxxxxx. : understanding onc-omics for patient-tailored cancer therapy.

Promises and challenges of developing new drugs in oncology

Regional Young Investigator SIC meeting. 5-6 March 2015

EACR AACR SIC. from Cancer Biology to the Clinic. Advance Programme & Call for Abstracts ITALY JUNE. Anticancer Drug Action and Drug Resistance:

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

POST-CONGRESS SATELLITE MEETINGS May 24 th, Cancer biomarkers 2013

INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY June 2015

LIQUID BIOPSY: TRACKING CANCER

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France September 2008

Advances in Biology and Treatment of Malignant Brain Gliomas

Scientific Programme

T u m o r D o r m a n c y

Project ideas of University of Udine for Horizon 2020 Health 2014/2015

CARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM

Biogenic Amines 2011

Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens

AICC Italian Association of Cell Culture

Elective Options for MS in Clinical and Translational Sciences Program

How To Learn More About Melanoma

Ph.D. in Molecular Medicine

Rome, 9-10 June 2016

FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES

Mediterranean School of Oncology

Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS

9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium

2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy

Future Oncology: Technology, Products, Market and Service Opportunities

on End Stage Focus on Idiopathic

XXIII AINI Congress Italian Association of Neuroimmunology Milan (Italy) August 22 nd, 2013

FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.

Monday 27 th October ,00-14,00 Registration 12,30-14,00 Welcome Buffet

1 st CIRCULAR. ICE XI International Congress of Egyptologists XI. Florence (Italy) August 23 rd 30 th 2015

Genomics in Hematology

Master Online Study Oncology. Study part time team up internationally!

CONTRASTS IN PHARMACOLOGY 2.0

Complement in human disease, September 8th - 12th 2017

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

INTERNATIONAL COURSE:

FASEB Directory of Members Online

Clinical Cancer Research: Alternative IRB Models and Enhancing Progress

Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum

Haploidentical Stem Cell Transplantation

Breast Pathology Masterclass 2016

MATWIN Programme 2015 Support for the Proof of Concept Project Application Form

Centro CARDIOLOGICO Monzino - IRCCS

Interna'onal congress on Cancer cell death and resistance

FIRST ITALIAN CHAPTER MEETING

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

International symposium on: The Impact of Genomic Deep Sequencing on

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

VII MEETING OF MOLECULAR ONCOLOGY

5 Th. 5 th Lugano Stem Cell Meeting. 20 th 21 st June Università della Svizzera Italiana Lugano Switzerland PRELIMINARY PROGRAM

FACULTY OF MEDICAL SCIENCE

2 Year ( ) CLL/SLL Research Initiative CLL/SLL Collaborative Grant

PERSONALIZED CANCER TREATMENT A multidisciplinary event

Guidelines for Applicants

International Workshop TRANSLATIONAL RESEARCH ON MALIGNANT GLIOMAS: FROM DISCOVERY TO CLINIC

MS: from disease management to patient management

13 May 14 May. SESSION 2.- Advances in hearing loss research II Chair: Andrew Forge

5 February Bari, Italy

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

"GRANITIC PEGMATITES: THE STATE OF THE ART"

Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes

29 January Rome, Italy

FIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE. Porto Pirgos Hotel ( Parghelia (VV), Calabria, Italy

PULMONARY HYPERTENSION. This meeting is fully sponsored by GlaxoSmithKline and jointly organised with the Meeting Faculty and GlaxoSmithKline

Skeletal Endocrinology

How To Understand And Treat Pain In Neurobiological Conditions

SPONSORSHIP/ADVERTIZING OPPORTUNITIES

Eventuale spazio per nome struttura o altro. Pharmacy education. The Italian academic viewpoint

IPMSC First Scientific Conference Daily Program

INVITATION. 48th Annual Scientific Meeting of the European Society for Clinical Investigation. 30 April - 3 May 2014 Utrecht, the Netherlands

Colorectal cancer xenopatients: A preclinical platform for precision medicine

Nuevas tecnologías basadas en biomarcadores para oncología

I Module Crime Scene & Forensic Genetics

A leader in the development and application of information technology to prevent and treat disease.

Version Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

MADRID 11/06/09 EPIGENETICS AND NEW THERAPIES IN CANCER June 2009 Madrid, Spain ESO INSIDE TRACK CONFERENCE

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7)

MOLECULAR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

2015 Feb.4th. AROME Radiobiology Course and Innovations: from biology to clinical practice of hypo fractionation and Stereotactic Radiotherapy

STRATEGY PROGRAM NEXT LEVEL BERLIN, 9 JUNE 2016

Clinical Research Infrastructure

UPDATE ON BONE METASTASES

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

A Guide to the ABTA s 2013 Medical Student Summer Fellowship Application

Pharmacogenomics and theranostics in practice

Theories on Metastasis: Innovative Thinking An Advocacy Perspective

An Introduction To Immunotherapy And The Promise Of Tissue Phenomics

CORPORATE SUPPORT OPPORTUNITIES

Transcription:

SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA Preliminary Program

Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Scientific Program Monday, September 5 th 13:30 Registration Local Scientific Committee Vincenzo Bronte (Verona) Carmine Carbone (Verona) Geny Piro (Verona) Raffaela Santoro (Verona) Aldo Scarpa (Verona) 15.00-15.30 Welcome opening 15.30-16.30 Opening lecture Mechanisms of Resistance to Endocrine Therapy: Insights from Translational Studies in Breast Cancer Carlos L. Arteaga (USA) 16.30-17.00 Coffee break SIC Secretariat Società Italiana di Cancerologia Via G. Venezian, 1 20133 Milano MI E-mail: sic@istitutotumori.mi.it www.cancerologia.it Organizing Secretariat Via Sassonia, 30 47922 Rimini RN E-mail: sic2016@adriacongrex.it www.adriacongrex.it SIC Scientific Board President Silvia Giordano (Turin) President Elect Gabriella Sozzi (Milan) Board Rita Falcioni (Rome) Davide Melisi (Verona) Nicola Normanno (Naples) Massimo Santoro (Naples) Elda Tagliabue (Milan) Giulia Taraboletti (Bergamo) Giuseppe Viglietto (Catanzaro) Member under 35 Marco Macagno (Turin) Selena Ventura (Bologna) Past President Riccardo Dolcetti (Aviano-PN) 17.00-19.00 Pancreatic cancer Claudio Bassi (Italy) Andrew V. Biankin (UK) Kras, IL-1alpha, NF-kappaB, and Inflammation: Dangerous Liaisons Paul J. Chiao (USA)

Tuesday, September 6 th 08.30-10.00 Metabolism and cancer Antiangiogenic therapy and metabolic evolution of tumors Stefano Indraccolo (Italy) Shutting your TRAP to kill tumors? The oncogenic role of the mitochondrial chaperone TRAP1 Andrea Rasola (Italy) 10.30-12.00 Clinical cancer genomics and heterogeneity 12.00-13.30 Lunch A Dynamic Episomal Basis for Therapeutic Resistance Webster K. Cavenee (USA) Colorectal cancer molecular heterogeneity: from patients to preclinical models, and back Enzo Medico (Italy) 13.30-14.30 Poster viewing with authors 14.30-15.45 Poster Discussion (2 parallel sessions) 15.45-17.00 Poster Discussion (2 parallel sessions) 17.00-17.30 Coffee break 17.30-19.00 Epigenetics/Non coding RNA Role of exosomic micrornas in the biology of the Tumor Microenvironment Muller Fabbri (USA) Yap/Taz at the roots of cancer Stefano Piccolo (Italy) Wednesday, September 7 th 08.30-10.00 Tumor microenvironment Breaking Bad: cancer associated fibroblasts are reprogrammed from growth inhibitory to tumor-promoting in breast Neta Erez (Israel) Fgf-trap Molecules For Cancer Therapy Marco Presta (Italy) 10.30-12.30 SIC meets Pharma Industry 12.30-14.00 Lunch 14.00-15.30 Joint meeting SIC-ESMO: New combination strategies Michele Milella (Italy) To be defined 15.30-16.00 Coffee break Evolving intratumor heterogeneity in glioblastoma Joan Seoane (Spain) Cancer precision medicine in colorectal cancer: Opportunities and challenges Livio Trusolino (Italy) 16.00-17.00 Poster viewing with authors 17.00-19.00 Cancer immunotherapy Mechanisms of response and resistance to immune checkpoint blockade in solid tumors Andrea Anichini (Italy) Vincenzo Bronte (Italy) RNA based cancer immunotherapy Ugur Sahin (Germany)

Abstract Thursday, September 8 th 08.30-10.00 New targets / New models Vincenzo Cerullo (Finland) The dependence receptor paradigm: from an alternative cell death pathway to novel drugs entering clinical trials Patrick Mehlen (France) 10.30-12.00 Giorgio Prodi Lecture 12.00-13.00 Award ceremony Piero Trivella awards for the best posters Guido Berlucchi Foundation awards for the best posters Guido Berlucchi Foundation award for the best oral presentation Elena Cappannini award for the best 2015 publication Pezcoller Foundation scholarship 2015-2016 winner award Pezcoller Foundation scholarship 2017-2018 award 13.00-14.00 Closing lecture Giorgio Trinchieri (USA) 14:00 Closing remarks Abstract submission The organizers invite authors to submit abstracts for consideration and inclusion in the programme. Abstracts must be sent by May 2, 2016 and must focus on the following topics: Animal models of cancer Autophagy, apoptosis, necrosis and senescence Cancer genetics, genomics and epigenetics Cancer modeling and imaging Cancer stem cells Carcinogenesis Cell adhesion, migration, invasion and metastasis Cell metabolism Chemoprevention and early detection DNA damage and molecular responses to damage Drug resistance Experimental therapeutics Molecular and genetic epidemiology Molecular pathology Nanotechnology Non-coding RNAs Novel therapeutic targets Oncogenes and tumor suppressor genes Personalized medicine Prognostic and predictive biomarkers Signal transduction and intracellular trafficking System biology and OMICS technologies Tumor heterogeneity Tumor immunology and immunotherapy Tumor microenvironment: inflammation, hypoxia and angiogenesis Abstracts must be written in English and must not exceed 2.500 characters (including blanks and excluding the title and the authors). All submitted abstracts will be reviewed by a Scientific Committee and selected for oral or poster presentations (sizes: cm 70x100h.). Abstracts must be sent using the online form. Abstracts sent in any other way will not be accepted. Notification of acceptance or rejection, together with information about session, date, time and type of presentation, will follow. Each Author can present only one abstract. Abstracts will be included in the Programme and in the Abstract book only if the Presenting Author will be regularly registered in the Congress.

th 58 September 5-8 2016 Palazzo della GRAN GUARDIA General Information Registration Fees Early registration Late registration On-site by June 15, 2016 by August 25, 2016 registration SIC MEMBER* 360,00 410,00 450,00 NON SIC MEMBER** 460,00 510,00 550,00 SIC MEMBER UNDER 35* 210,00 260,00 280,00 NON SIC MEMBER UNDER 35** 270,00 330,00 360,00 (*)VAT non applicable as for law ex Art.4 DPR 633/72; (**) VAT 22% included The VAT rate will be applied depending on the Italian fiscal law at the time of payment. Registration fees include: admission to the scientific sessions admission to the exhibition area name badge and congress kit abstracts book attendance certificate ECM certificate welcome cocktail, coffee breaks, light lunches and social dinner Registrations can be requested submitting the registration form online: www.adriacongrex.it/sic2016. E-mail: sic2016@adriacongrex.it; Fax +39 0541 305842 Registrations without payment will not be accepted. Payment Methods and Details Payment should be made by one of the following methods: Bank transfer Please transfer the payment to Adria Congrex Bank details: IT 18 N 06285 24214 CC0142118559 The payment transfer form should clearly state SIC 2016 Code 0680615AMVE and the name(s) of the delegate(s). Credit card All major credit cards are accepted (American Express, VISA, Mastercard, Cartasi). REGISTRATIONS WILL BE PROCESSED ONLY WHEN ACCOMPANIED BY THE TOTAL PAYMENT. Cancellation In case of cancellation reimbursement will not be done.